Docetaxel in the Treatment of Hormone Refractory Prostate Cancer
Evaluation of safety and efficacy of docetaxel in the treatment of advanced hormone refractory prostate cancer under the conditions of daily practise.
Prostatic Neoplasms
DRUG: docetaxel
PSA decline, after each docetaxel administration and after the end of treatment|pain response, after each docetaxel administration and after the end of treatment|side effects occurrence, Throughout the study
Evaluation of safety and efficacy of docetaxel in the treatment of advanced hormone refractory prostate cancer under the conditions of daily practise.